Fortis Healthcare shares outlook by Nomura: Rating neutral and target price remains ₹1030
60-Word AI Digest
Fortis Healthcare shares outlook by Nomura: Rating neutral and target price remains ₹1030. Reporting by check rationale highlights major developments in this space as key stakeholders evaluate broader implications. Further data and contextual analysis are actively being published. Access the full coverage dispatch below for complete documentation.
Key Takeaways
- Fortis Healthcare shares outlook by Nomura: Rating neutral and target price remains ₹1030
- Fortis Healthcare’s share price has remained under pressure in the near term, declining 4.61% over the past week and 6.04% over the last month
- Click full coverage link below for the complete official dispatch.
Fortis Healthcare’s share price has remained under pressure in the near term, declining 4.61% over the past week and 6.04% over the last month
Original Publisher Attribution
This summary was curated from check rationale.